Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4

Hypertension

Volumn 55, Issue 5, 2010, Pages 1110-1115

  Ford, Martin L ^a   Tomlinson, Laurie A ^a   Chapman, Thomas P E ^b   Rajkumar, Chakravarthi ^a   Holt, Stephen G ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UK   (United Kingdom)

Author keywords

Aorta; Creatinine; Kidney; Microvessels; Pulse pressure; Renal insufficiency

Indexed keywords

CREATININE;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AORTA; AORTIC DISEASES; BIOSTATISTICS; BLOOD PRESSURE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MULTIVARIATE ANALYSIS; NEPHRITIS, INTERSTITIAL; PATIENT SELECTION; PROTEINURIA; PYELONEPHRITIS; REGRESSION ANALYSIS;

EID: 77951498243     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.143024     Document Type: Article

References (38)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047. (Pubitemid 350074801)
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305. (Pubitemid 39268908)
3. Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005;45:494-501.
4. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, Ishimura E, Tabata T, Nishizawa Y. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001;12:2117-2124. (Pubitemid 32880348)
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434-2439. (Pubitemid 29218240)
6. Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens. 2007;25:1915-1920. (Pubitemid 47356633)
7. Gosse P, Safar ME. Arterial stiffness and plasma creatinine in untreated hypertensive patients. Am J Hypertens. 2005;18:1140-1145. (Pubitemid 41337965)
8. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200-204.
9. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008;105:1652-1660.
10. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605. (Pubitemid 44627304)
11. Burden R, Tomson C. Identification, management and referral of adults with chronic kidney disease: concise guidelines. Clin Med. 2005;5: 635-642. (Pubitemid 41826495)
12. Sever P. New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society. J Renin Angiotensin Aldosterone Syst. 2006;7:61-63. (Pubitemid 44383500)
13. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac A-M, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension. 1995;26:485-490.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creat-inine: a new prediction equation-Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
15. Nichols WM, O'Rourke MF. McDonald's Blood Flow in Arteries. 5th ed. London, United Kingdom: Hodder Arnold; 2005.
16. Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P. Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive. J Hypertens. 2009;27:1303-1308.
17. Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003; 163:1555-1565. (Pubitemid 36835100)
18. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18. (Pubitemid 26012498)
19. Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006;17: 2582-2590. (Pubitemid 44300975)
20. Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, Froissart M, Houillier P, Boutouyrie P. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int. 2006;69:350-357. (Pubitemid 43323087)
21. Lacy P, Carr SJ, O'Brien D, Fentum B, Williams B, Paul SK, Robinson TG. Reduced glomerular filtration rate in pre-dialysis non-diabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Clin Sci (Lond). 2006;110: 101-108. (Pubitemid 43059049)
22. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, Thomas F, Pannier B, Asmar R, Zureik M, Safar M, Guize L. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002;105:1202-1207. (Pubitemid 34225821)
23. Al-Nimri MA, Komers R, Oyama TT, Subramanya AR, Lindsley JN, Anderson S. Endothelial-derived vasoactive mediators in polycystic kidney disease. Kidney Int. 2003;63:1776-1784. (Pubitemid 36513323)
24. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65:1009-1016. (Pubitemid 38251077)
25. Dogra G, Irish A, Chan D, Watts G. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis. 2006;48:926-934. (Pubitemid 44895366)
26. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244-252. (Pubitemid 38129085)
27. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95:560-567. (Pubitemid 39274370)
28. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF, Davies JS. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85:3515-3519.
29. Zoungas S, Kerr PG, Chadban S, Muske C, Ristevski S, Atkins RC, McNeil JJ, McGrath BP. Arterial function after successful renal transplantation. Kidney Int. 2004;65:1882-1889. (Pubitemid 38591040)
30. Takenaka T, Mimura T, Kanno Y, Suzuki H. Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol. 2005;25:417-424. (Pubitemid 41433884)
31. Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract. 2007;107:177-181.
32. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, Meigs JB, Larson MG, Levy D, Benjamin EJ, Fox CS. Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol. 2009;20:2044-2053.
33. Nichols W, O'Rourke M. McDonald's Blood Flow in Arteries. 3rd ed. London, United Kingdom: Edward Arnold; 1990.
34. Mitchell GF. Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension. 2004;43:151-153.
35. Loutzenhiser R, Bidani A, Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res. 2002;90:1316-1324. (Pubitemid 34787414)
36. Griffin KA, Picken MM, Churchill M, Churchill P, Bidani AK. Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol. 2000;11:497-506. (Pubitemid 30115079)
37. Hill GS, Heudes D, Jacquot C, Gauthier E, Bariety J. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int. 2006;69:823-831. (Pubitemid 43297891)
38. Kass DA. Age-related changes in ventricular-arterial coupling: patophys-iological implications. Heart Fail Rev. 2002;7:51-62.